{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T03:16:09Z","timestamp":1788146169842,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NCI","award":["1F30CA257269"],"award-info":[{"award-number":["1F30CA257269"]}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-18-1-0019"],"award-info":[{"award-number":["W81XWH-18-1-0019"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL112626-06A1"],"award-info":[{"award-number":["HL112626-06A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02331-7","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:24:15Z","timestamp":1781893455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor cell Jagged-1 promotes regional lymphatic metastasis and predicts recurrence in node-positive breast cancer"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3856-0500","authenticated-orcid":false,"given":"Benjamin","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhairavi","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seock Won","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8804-5497","authenticated-orcid":false,"given":"Natalia Anna","family":"Obacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Vadakath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Teneqexhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Alvarez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rezola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0052-511X","authenticated-orcid":false,"given":"Sara","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhara","family":"Telletxea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-9684","authenticated-orcid":false,"given":"Ekrem Emrah","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5031-4804","authenticated-orcid":false,"given":"L. A.","family":"Naiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-6827","authenticated-orcid":false,"given":"Maria","family":"M. Caffarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4660-593X","authenticated-orcid":false,"given":"Jan","family":"Kitajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"1","key":"2331_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"2331_CR2","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1200\/JCO.2007.12.6425","volume":"26","author":"LK Tan","year":"2008","unstructured":"Tan LK, Giri D, Hummer AJ, Panageas KS, Brogi E, Norton L, Hudis C, Borgen PI, Cody HS. 3rd: Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol. 2008;26(11):1803\u20139.","journal-title":"J Clin Oncol"},{"issue":"9","key":"2331_CR3","doi-asserted-by":"publisher","first-page":"e20221847","DOI":"10.1084\/jem.20221847","volume":"220","author":"PJ Van Lei","year":"2023","unstructured":"Lei PJ, Pereira ER, Andersson P, Amoozgar Z, Van Wijnbergen JW, O\u2019Melia MJ, Zhou H, Chatterjee S, Ho WW, Posada JM, et al. Cancer cell plasticity and MHC-II-mediated immune tolerance promote breast cancer metastasis to lymph nodes. J Exp Med. 2023;220(9):e20221847.","journal-title":"J Exp Med"},{"issue":"12","key":"2331_CR4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.tcb.2023.04.001","volume":"33","author":"NE Reticker-Flynn","year":"2023","unstructured":"Reticker-Flynn NE, Engleman EG. Lymph nodes: at the intersection of cancer treatment and progression. Trends Cell Biol. 2023;33(12):1021\u201334.","journal-title":"Trends Cell Biol"},{"issue":"11","key":"2331_CR5","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","volume":"185","author":"NE Reticker-Flynn","year":"2022","unstructured":"Reticker-Flynn NE, Zhang W, Belk JA, Basto PA, Escalante NK, Pilarowski GOW, Bejnood A, Martins MM, Kenkel JA, Linde IL, et al. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell. 2022;185(11):1924\u201342. e1923.","journal-title":"Cell"},{"issue":"2","key":"2331_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1158\/2159-8290.CD-20-0122","volume":"11","author":"N Gengenbacher","year":"2021","unstructured":"Gengenbacher N, Singhal M, Mogler C, Hai L, Milde L, Pari AAA, Besemfelder E, Fricke C, Baumann D, Gehrs S, et al. Timed Ang2-Targeted Therapy Identifies the Angiopoietin-Tie Pathway as Key Regulator of Fatal Lymphogenous Metastasis. Cancer Discov. 2021;11(2):424\u201345.","journal-title":"Cancer Discov"},{"issue":"1","key":"2331_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1158\/0008-5472.CAN-08-1875","volume":"69","author":"A Issa","year":"2009","unstructured":"Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res. 2009;69(1):349\u201357.","journal-title":"Cancer Res"},{"issue":"6","key":"2331_CR8","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ijc.10283","volume":"98","author":"MM Mattila","year":"2002","unstructured":"Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K, H\u00e4rk\u00f6nen PL. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer. 2002;98(6):946\u201351.","journal-title":"Int J Cancer"},{"issue":"15","key":"2331_CR9","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.3390\/cancers14153602","volume":"14","author":"E Sibler","year":"2022","unstructured":"Sibler E, He Y, Ducoli L, Rihs V, Sidler P, Puig-Moreno C, Frey J, Fujimoto N, Detmar M, Dieterich LC. Immunomodulatory responses of subcapsular sinus floor lymphatic endothelial cells in tumor-draining lymph nodes. Cancers (Basel). 2022;14(15):3602.","journal-title":"Cancers (Basel)"},{"key":"2331_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fcvm.2020.00052","volume":"7","author":"M Xiang","year":"2020","unstructured":"Xiang M, Grosso RA, Takeda A, Pan J, Bekkhus T, Brulois K, Dermadi D, Nordling S, Vanlandewijck M, Jalkanen S, et al. A single-cell transcriptional roadmap of the mouse and human lymph node lymphatic vasculature. Front Cardiovasc Med. 2020;7:52.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"2331_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ccell.2017.01.007","volume":"31","author":"E Wieland","year":"2017","unstructured":"Wieland E, Rodriguez-Vita J, Liebler SS, Mogler C, Moll I, Herberich SE, Espinet E, Herpel E, Menuchin A, Chang-Claude J, et al. Endothelial Notch1 activity facilitates metastasis. Cancer Cell. 2017;31(3):355\u201367.","journal-title":"Cancer Cell"},{"issue":"4","key":"2331_CR12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","volume":"34","author":"O Meurette","year":"2018","unstructured":"Meurette O, Mehlen P. Notch Signaling in the Tumor Microenvironment. Cancer Cell. 2018;34(4):536\u201348.","journal-title":"Cancer Cell"},{"issue":"1","key":"2331_CR13","doi-asserted-by":"publisher","first-page":"21986","DOI":"10.1038\/s41598-022-26241-8","volume":"12","author":"X Qiao","year":"2022","unstructured":"Qiao X, Ma B, Sun W, Zhang N, Liu Y, Jia L, Liu C. JAG1 is associated with the prognosis and metastasis in breast cancer. Sci Rep. 2022;12(1):21986.","journal-title":"Sci Rep"},{"issue":"18","key":"2331_CR14","doi-asserted-by":"publisher","first-page":"8530","DOI":"10.1158\/0008-5472.CAN-05-1069","volume":"65","author":"M Reedijk","year":"2005","unstructured":"Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, Lockwood G, Egan SE. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005;65(18):8530\u20137.","journal-title":"Cancer Res"},{"issue":"2","key":"2331_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1373\/clinchem.2015.246686","volume":"62","author":"N Bednarz-Knoll","year":"2016","unstructured":"Bednarz-Knoll N, Efstathiou A, Gotzhein F, Wikman H, Mueller V, Kang Y, Pantel K. Potential involvement of jagged1 in metastatic progression of human breast carcinomas. Clin Chem. 2016;62(2):378\u201386.","journal-title":"Clin Chem"},{"issue":"6","key":"2331_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/modpathol.3800785","volume":"20","author":"BC Dickson","year":"2007","unstructured":"Dickson BC, Mulligan AM, Zhang H, Lockwood G, O\u2019Malley FP, Egan SE, Reedijk M. High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod Pathol. 2007;20(6):685\u201393.","journal-title":"Mod Pathol"},{"issue":"3","key":"2331_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10549-007-9805-3","volume":"111","author":"M Reedijk","year":"2008","unstructured":"Reedijk M, Pinnaduwage D, Dickson BC, Mulligan AM, Zhang H, Bull SB, O\u2019Malley FP, Egan SE, Andrulis IL. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res Treat. 2008;111(3):439\u201348.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2331_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1158\/2159-8290.CD-14-0650","volume":"5","author":"T Kangsamaksin","year":"2015","unstructured":"Kangsamaksin T, Murtomaki A, Kofler NM, Cuervo H, Chaudhri RA, Tattersall IW, Rosenstiel PE, Shawber CJ, Kitajewski J. NOTCH decoys that selectively block DLL\/NOTCH or JAG\/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth. Cancer Discov. 2015;5(2):182\u201397.","journal-title":"Cancer Discov"},{"key":"2331_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12967-015-0386-3","volume":"13","author":"P Ghiabi","year":"2015","unstructured":"Ghiabi P, Jiang J, Pasquier J, Maleki M, Abu-Kaoud N, Halabi N, Guerrouahen BS, Rafii S, Rafii A. Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche. J Transl Med. 2015;13:27.","journal-title":"J Transl Med"},{"issue":"6","key":"2331_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ccell.2017.11.002","volume":"32","author":"H Zheng","year":"2017","unstructured":"Zheng H, Bae Y, Kasimir-Bauer S, Tang R, Chen J, Ren G, Yuan M, Esposito M, Li W, Wei Y, et al. Therapeutic antibody targeting tumor- and osteoblastic niche-derived Jagged1 sensitizes bone metastasis to chemotherapy. Cancer Cell. 2017;32(6):731\u201347. e736.","journal-title":"Cancer Cell"},{"issue":"20","key":"2331_CR21","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1158\/0008-5472.CAN-17-0357","volume":"77","author":"RA Sierra","year":"2017","unstructured":"Sierra RA, Trillo-Tinoco J, Mohamed E, Yu L, Achyut BR, Arbab A, Bradford JW, Osborne BA, Miele L, Rodriguez PC. Anti-Jagged Immunotherapy inhibits MDSCs and overcomes tumor-induced tolerance. Cancer Res. 2017;77(20):5628\u201338.","journal-title":"Cancer Res"},{"issue":"10","key":"2331_CR22","doi-asserted-by":"publisher","first-page":"110492","DOI":"10.1016\/j.celrep.2022.110492","volume":"38","author":"J Meng","year":"2022","unstructured":"Meng J, Jiang YZ, Zhao S, Tao Y, Zhang T, Wang X, Zhang Y, Sun K, Yuan M, Chen J, et al. Tumor-derived Jagged1 promotes cancer progression through immune evasion. Cell Rep. 2022;38(10):110492.","journal-title":"Cell Rep"},{"issue":"2","key":"2331_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ccr.2010.12.022","volume":"19","author":"N Sethi","year":"2011","unstructured":"Sethi N, Dai X, Winter CG, Kang Y. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell. 2011;19(2):192\u2013205.","journal-title":"Cancer Cell"},{"issue":"2","key":"2331_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10456-021-09822-5","volume":"25","author":"A Muley","year":"2022","unstructured":"Muley A, Kim Uh M, Salazar-De Simone G, Swaminathan B, James JM, Murtomaki A, Youn SW, McCarron JD, Kitajewski C, Gnarra Buethe M, et al. Unique functions for Notch4 in murine embryonic lymphangiogenesis. Angiogenesis. 2022;25(2):205\u201324.","journal-title":"Angiogenesis"},{"issue":"11","key":"2331_CR25","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1242\/dev.083865","volume":"140","author":"A Murtomaki","year":"2013","unstructured":"Murtomaki A, Uh MK, Choi YK, Kitajewski C, Borisenko V, Kitajewski J, Shawber CJ. Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium. Development. 2013;140(11):2365\u201376.","journal-title":"Development"},{"issue":"12","key":"2331_CR26","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1242\/dev.101188","volume":"141","author":"A Murtomaki","year":"2014","unstructured":"Murtomaki A, Uh MK, Kitajewski C, Zhao J, Nagasaki T, Shawber CJ, Kitajewski J. Notch signaling functions in lymphatic valve formation. Development. 2014;141(12):2446\u201351.","journal-title":"Development"},{"issue":"11","key":"2331_CR27","doi-asserted-by":"publisher","first-page":"a041183","DOI":"10.1101\/cshperspect.a041183","volume":"12","author":"LA Naiche","year":"2022","unstructured":"Naiche LA, Villa SR, Kitajewski JK. Endothelial cell fate determination: a top notch job in vascular decision-making. Cold Spring Harb Perspect Med. 2022;12(11):a041183.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"2331_CR28","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1172\/JCI24311","volume":"117","author":"CJ Shawber","year":"2007","unstructured":"Shawber CJ, Funahashi Y, Francisco E, Vorontchikhina M, Kitamura Y, Stowell SA, Borisenko V, Feirt N, Podgrabinska S, Shiraishi K, et al. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J Clin Invest. 2007;117(11):3369\u201382.","journal-title":"J Clin Invest"},{"issue":"4","key":"2331_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10585-023-10214-w","volume":"40","author":"S Janeva","year":"2023","unstructured":"Janeva S, Parris TZ, Krabbe E, Sundquist M, Karlsson P, Audisio RA, Olofsson Bagge R, Kov\u00e1cs A. Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases. Clin Exp Metastasis. 2023;40(4):299\u2013308.","journal-title":"Clin Exp Metastasis"},{"issue":"3","key":"2331_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3677","volume":"14","author":"SA Stacker","year":"2014","unstructured":"Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer. 2014;14(3):159\u201372.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2331_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.critrevonc.2013.08.014","volume":"89","author":"FJ Gujam","year":"2014","unstructured":"Gujam FJ, Going JJ, Edwards J, Mohammed ZM, McMillan DC. The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer. Crit Rev Oncol Hematol. 2014;89(2):231\u201341.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"2331_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/01.sla.0000133355.48672.22","volume":"240","author":"SF Schoppmann","year":"2004","unstructured":"Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg. 2004;240(2):306\u201312.","journal-title":"Ann Surg"},{"issue":"4","key":"2331_CR33","doi-asserted-by":"publisher","first-page":"R444","DOI":"10.1186\/bcr1026","volume":"7","author":"DE Jenkins","year":"2005","unstructured":"Jenkins DE, Hornig YS, Oei Y, Dusich J, Purchio T. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Res. 2005;7(4):R444\u2013454.","journal-title":"Breast Cancer Res"},{"issue":"7718","key":"2331_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","volume":"560","author":"U Ben-David","year":"2018","unstructured":"Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, Strathdee CA, Dempster J, Lyons NJ, Burns R, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. 2018;560(7718):325\u201330.","journal-title":"Nature"},{"issue":"4","key":"2331_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/8756-3282(85)90008-0","volume":"6","author":"AE Grigoriadis","year":"1985","unstructured":"Grigoriadis AE, Petkovich PM, Ber R, Aubin JE, Heersche JN. Subclone heterogeneity in a clonally-derived osteoblast-like cell line. Bone. 1985;6(4):249\u201356.","journal-title":"Bone"},{"key":"2331_CR36","doi-asserted-by":"publisher","first-page":"952581","DOI":"10.3389\/fphar.2022.952581","volume":"13","author":"PS Russell","year":"2022","unstructured":"Russell PS, Velivolu R, Maldonado Zimbron VE, Hong J, Kavianinia I, Hickey AJR, Windsor JA, Phillips ARJ. Fluorescent Tracers for In Vivo Imaging of Lymphatic Targets. Front Pharmacol. 2022;13:952581.","journal-title":"Front Pharmacol"},{"issue":"389","key":"2331_CR37","doi-asserted-by":"publisher","first-page":"eaal3920","DOI":"10.1126\/scitranslmed.aal3920","volume":"9","author":"W Tian","year":"2017","unstructured":"Tian W, Rockson SG, Jiang X, Kim J, Begaye A, Shuffle EM, Tu AB, Cribb M, Nepiyushchikh Z, Feroze AH, et al. Leukotriene B(4) antagonism ameliorates experimental lymphedema. Sci Transl Med. 2017;9(389):eaal3920.","journal-title":"Sci Transl Med"},{"issue":"8","key":"2331_CR38","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00262-020-02792-5","volume":"70","author":"MJ O\u2019Melia","year":"2021","unstructured":"O\u2019Melia MJ, Manspeaker MP, Thomas SN. Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC. Cancer Immunol Immunother. 2021;70(8):2179\u201395.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"2331_CR39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.acra.2010.11.012","volume":"18","author":"F Sheng","year":"2011","unstructured":"Sheng F, Inoue Y, Kiryu S, Watanabe M, Ohtomo K. Lymph drainage from the mammary glands in mice: a magnetic resonance lymphographic study with gadofluorine M. Acad Radiol. 2011;18(4):512\u20137.","journal-title":"Acad Radiol"},{"issue":"16","key":"2331_CR40","doi-asserted-by":"publisher","first-page":"8065","DOI":"10.1158\/0008-5472.CAN-06-1392","volume":"66","author":"T Hoshida","year":"2006","unstructured":"Hoshida T, Isaka N, Hagendoorn J, di Tomaso E, Chen YL, Pytowski B, Fukumura D, Padera TP, Jain RK. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res. 2006;66(16):8065\u201375.","journal-title":"Cancer Res"},{"issue":"5574","key":"2331_CR41","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1126\/science.1071420","volume":"296","author":"TP Padera","year":"2002","unstructured":"Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 2002;296(5574):1883\u20136.","journal-title":"Science"},{"issue":"3","key":"2331_CR42","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","volume":"20","author":"J Chuprin","year":"2023","unstructured":"Chuprin J, Buettner H, Seedhom MO, Greiner DL, Keck JG, Ishikawa F, Shultz LD, Brehm MA. Humanized mouse models for immuno-oncology research. Nat Rev Clin Oncol. 2023;20(3):192\u2013206.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"2331_CR43","first-page":"1399","volume":"52","author":"CJ Aslakson","year":"1992","unstructured":"Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992;52(6):1399\u2013405.","journal-title":"Cancer Res"},{"issue":"2","key":"2331_CR44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/84643","volume":"7","author":"M Skobe","year":"2001","unstructured":"Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7(2):192\u20138.","journal-title":"Nat Med"},{"issue":"5","key":"2331_CR45","first-page":"1786","volume":"61","author":"T Karpanen","year":"2001","unstructured":"Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yl\u00e4-Herttuala S, J\u00e4\u00e4ttel\u00e4 M, Alitalo K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 2001;61(5):1786\u201390.","journal-title":"Cancer Res"},{"issue":"2","key":"2331_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10456-021-09822-5","volume":"25","author":"A Muley","year":"2022","unstructured":"Muley A, Kim Uh M, Salazar-De Simone G, Swaminathan B, James JM, Murtomaki A, Shawber CJ. Unique functions for Notch4 in murine embryonic lymphangiogenesis. Angiogenesis. 2022;25(2):205\u201324.","journal-title":"Angiogenesis"},{"key":"2331_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ydbio.2021.12.005","volume":"482","author":"G Oliver","year":"2022","unstructured":"Oliver G. Lymphatic endothelial cell fate specification in the mammalian embryo: An historical perspective. Dev Biol. 2022;482:44\u201354.","journal-title":"Dev Biol"},{"issue":"1","key":"2331_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/cells13010068","volume":"13","author":"K Kuonqui","year":"2023","unstructured":"Kuonqui K, Campbell AC, Sarker A, Roberts A, Pollack BL, Park HJ, Shin J, Brown S, Mehrara BJ, Kataru RP. Dysregulation of lymphatic endothelial VEGFR3 signaling in disease. Cells. 2023;13(1):68.","journal-title":"Cells"},{"issue":"6","key":"2331_CR49","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/ijc.20509","volume":"112","author":"V Kirkin","year":"2004","unstructured":"Kirkin V, Thiele W, Baumann P, Mazitschek R, Rohde K, Fellbrich G, Weich H, Waltenberger J, Giannis A, Sleeman JP. MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo. Int J Cancer. 2004;112(6):986\u201393.","journal-title":"Int J Cancer"},{"issue":"21","key":"2331_CR50","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1046\/j.1432-1033.2001.02476.x","volume":"268","author":"V Kirkin","year":"2001","unstructured":"Kirkin V, Mazitschek R, Krishnan J, Steffen A, Waltenberger J, Pepper MS, Giannis A, Sleeman JP. Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. Eur J Biochem. 2001;268(21):5530\u201340.","journal-title":"Eur J Biochem"},{"issue":"6","key":"2331_CR51","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1182\/blood-2004-07-2547","volume":"105","author":"H Suzuki","year":"2005","unstructured":"Suzuki H, Watabe T, Kato M, Miyazawa K, Miyazono K. Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells. Blood. 2005;105(6):2372\u20139.","journal-title":"Blood"},{"issue":"5","key":"2331_CR52","doi-asserted-by":"publisher","first-page":"e2200041","DOI":"10.1002\/adbi.202200041","volume":"7","author":"A Bogseth","year":"2023","unstructured":"Bogseth A, Ramirez A, Vaughan E, Maisel K. In Vitro Models of Blood and Lymphatic Vessels-Connecting Tissues and Immunity. Adv Biol (Weinh). 2023;7(5):e2200041.","journal-title":"Adv Biol (Weinh)"},{"issue":"8","key":"2331_CR53","doi-asserted-by":"publisher","first-page":"e12730","DOI":"10.1111\/micc.12730","volume":"28","author":"AR Henderson","year":"2021","unstructured":"Henderson AR, Ilan IS, Lee E. A bioengineered lymphatic vessel model for studying lymphatic endothelial cell-cell junction and barrier function. Microcirculation. 2021;28(8):e12730.","journal-title":"Microcirculation"},{"issue":"1","key":"2331_CR54","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41598-022-05666-1","volume":"12","author":"B Swaminathan","year":"2022","unstructured":"Swaminathan B, Youn SW, Naiche LA, Du J, Villa SR, Metz JB, Feng H, Zhang C, Kopan R, Sims PA, et al. Endothelial Notch signaling directly regulates the small GTPase RND1 to facilitate Notch suppression of endothelial migration. Sci Rep. 2022;12(1):1655.","journal-title":"Sci Rep"},{"key":"2331_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fncel.2020.00096","volume":"14","author":"L Yi","year":"2020","unstructured":"Yi L, Liang Y, Zhao Q, Wang H, Dong J. CX3CL1 Induces Vertebral Microvascular Barrier Dysfunction via the Src\/P115-RhoGEF\/ROCK Signaling Pathway. Front Cell Neurosci. 2020;14:96.","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"2331_CR56","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1158\/1541-7786.MCR-18-0530","volume":"17","author":"M Roblek","year":"2019","unstructured":"Roblek M, Protsyuk D, Becker PF, Stefanescu C, Gorzelanny C, Glaus Garzon JF, Knopfova L, Heikenwalder M, Luckow B, Schneider SW, et al. CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis. Mol Cancer Res. 2019;17(3):783\u201393.","journal-title":"Mol Cancer Res"},{"key":"2331_CR57","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2016.10.043","volume":"385","author":"Z Wang","year":"2017","unstructured":"Wang Z, Wang Z, Li G, Wu H, Sun K, Chen J, Feng Y, Chen C, Cai S, Xu J, et al. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin beta1\/FAK\/AKT signaling. Cancer Lett. 2017;385:28\u201338.","journal-title":"Cancer Lett"},{"issue":"4","key":"2331_CR58","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ijc.26035","volume":"130","author":"J Xu","year":"2012","unstructured":"Xu J, Zhang C, He Y, Wu H, Wang Z, Song W, Li W, He W, Cai S, Zhan W. Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer. Int J Cancer. 2012;130(4):787\u201397.","journal-title":"Int J Cancer"},{"issue":"3","key":"2331_CR59","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.ajpath.2011.11.008","volume":"180","author":"K Kajiya","year":"2012","unstructured":"Kajiya K, Kidoya H, Sawane M, Matsumoto-Okazaki Y, Yamanishi H, Furuse M, Takakura N. Promotion of lymphatic integrity by angiopoietin-1\/Tie2 signaling during inflammation. Am J Pathol. 2012;180(3):1273\u201382.","journal-title":"Am J Pathol"},{"issue":"7","key":"2331_CR60","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1600-0625.2012.01526.x","volume":"21","author":"Y Matsumoto-Okazaki","year":"2012","unstructured":"Matsumoto-Okazaki Y, Furuse M, Kajiya K. Claudin-5 haploinsufficiency exacerbates UVB-induced oedema formation by inducing lymphatic vessel leakage. Exp Dermatol. 2012;21(7):557\u20139.","journal-title":"Exp Dermatol"},{"issue":"3","key":"2331_CR61","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/lrb.2010.0004","volume":"8","author":"GV Chaitanya","year":"2010","unstructured":"Chaitanya GV, Franks SE, Cromer W, Wells SR, Bienkowska M, Jennings MH, Ruddell A, Ando T, Wang Y, Gu Y, et al. Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro. Lymphat Res Biol. 2010;8(3):155\u201364.","journal-title":"Lymphat Res Biol"},{"issue":"5","key":"2331_CR62","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1469-7580.2008.00892.x","volume":"212","author":"Y Sawa","year":"2008","unstructured":"Sawa Y, Tsuruga E. The expression of E-selectin and chemokines in the cultured human lymphatic endothelium with lipopolysaccharides. J Anat. 2008;212(5):654\u201363.","journal-title":"J Anat"},{"issue":"4","key":"2331_CR63","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/sj.jid.5700670","volume":"127","author":"PR Clark","year":"2007","unstructured":"Clark PR, Manes TD, Pober JS, Kluger MS. Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations. J Invest Dermatol. 2007;127(4):762\u201374.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2331_CR64","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.4049\/jimmunol.179.6.4053","volume":"179","author":"MJ Allingham","year":"2007","unstructured":"Allingham MJ, van Buul JD, Burridge K. ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J Immunol. 2007;179(6):4053\u201364.","journal-title":"J Immunol"},{"key":"2331_CR65","doi-asserted-by":"publisher","first-page":"119225","DOI":"10.1016\/j.biomaterials.2019.119225","volume":"214","author":"MM Gong","year":"2019","unstructured":"Gong MM, Lugo-Cintron KM, White BR, Kerr SC, Harari PM, Beebe DJ. Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function. Biomaterials. 2019;214:119225.","journal-title":"Biomaterials"},{"issue":"2","key":"2331_CR66","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10456-013-9393-2","volume":"17","author":"WE Cromer","year":"2014","unstructured":"Cromer WE, Zawieja SD, Tharakan B, Childs EW, Newell MK, Zawieja DC. The effects of inflammatory cytokines on lymphatic endothelial barrier function. Angiogenesis. 2014;17(2):395\u2013406.","journal-title":"Angiogenesis"},{"issue":"11","key":"2331_CR67","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","volume":"9","author":"OD Gentilini","year":"2023","unstructured":"Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R, Luini A, Viale G, Cassano E, Peradze N, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: The SOUND randomized clinical trial. JAMA Oncol. 2023;9(11):1557\u201364.","journal-title":"JAMA Oncol"},{"issue":"10","key":"2331_CR68","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918\u201326.","journal-title":"JAMA"},{"issue":"6","key":"2331_CR69","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u201375.","journal-title":"JAMA"},{"issue":"8","key":"2331_CR70","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jamasurg.2023.1772","volume":"158","author":"S Kuemmel","year":"2023","unstructured":"Kuemmel S, Heil J, Bruzas S, Breit E, Schindowski D, Harrach H, Chiari O, Hellerhoff K, Bensmann E, Hanf V, et al. Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer. JAMA Surg. 2023;158(8):807\u201315.","journal-title":"JAMA Surg"},{"issue":"7","key":"2331_CR71","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11912-024-01539-0","volume":"26","author":"N Owusu-Brackett","year":"2024","unstructured":"Owusu-Brackett N, Facer B, Quiroga D, Pariser A, Grimm M, Beyer S, Jhawar S, Oppong BA. Axillary management: How much is too much? Curr Oncol Rep. 2024;26(7):735\u201343.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"2331_CR72","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.it.2022.10.010","volume":"44","author":"A Takeda","year":"2023","unstructured":"Takeda A, Salmi M, Jalkanen S. Lymph node lymphatic endothelial cells as multifaceted gatekeepers in the immune system. Trends Immunol. 2023;44(1):72\u201386.","journal-title":"Trends Immunol"},{"key":"2331_CR73","doi-asserted-by":"publisher","first-page":"1449291","DOI":"10.3389\/fimmu.2024.1449291","volume":"15","author":"PJ Lei","year":"2024","unstructured":"Lei PJ, Fraser C, Jones D, Ubellacker JM, Padera TP. Lymphatic system regulation of anti-cancer immunity and metastasis. Front Immunol. 2024;15:1449291.","journal-title":"Front Immunol"},{"issue":"13","key":"2331_CR74","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","volume":"390","author":"J de Boniface","year":"2024","unstructured":"de Boniface J, Filtenborg Tvedskov T, Ryd\u00e9n L, Szulkin R, Reimer T, K\u00fchn T, Kontos M, Gentilini OD, Olofsson Bagge R, Sund M, et al. Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases. N Engl J Med. 2024;390(13):1163\u201375.","journal-title":"N Engl J Med"},{"issue":"1","key":"2331_CR75","doi-asserted-by":"publisher","first-page":"10056","DOI":"10.1038\/s41467-025-64981-z","volume":"16","author":"D Eichin","year":"2025","unstructured":"Eichin D, Lehotina D, Kauko A, Uenaka M, Lepp\u00e4nen M, Elima K, Piipponen M, L\u00f6nnberg T, Bostr\u00f6m P, Koskivuo I, et al. Breast cancer remodels lymphatics in sentinel lymph nodes. Nat Commun. 2025;16(1):10056.","journal-title":"Nat Commun"},{"key":"2331_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14737140.2025.2464199","volume":"25","author":"AK Sanal","year":"2025","unstructured":"Sanal AK, Turan U, Yugruk A, Ta\u015f ZA, Irkorucu O, Taskin O. The discordance of biomarkers in primary tumour and synchronous axillary lymph node metastasis of the breast cancer, and its clinical significance in patients undergoing neoadjuvant therapy. Expert Rev Anticancer Ther. 2025;25:1\u20139.","journal-title":"Expert Rev Anticancer Ther"},{"key":"2331_CR77","doi-asserted-by":"publisher","first-page":"660318","DOI":"10.3389\/fonc.2021.660318","volume":"11","author":"W Kuncman","year":"2021","unstructured":"Kuncman W, Orzechowska M, Kuncman \u0141, Kordek R, Taran K. Intertumoral Heterogeneity of Primary Breast Tumors and Synchronous Axillary Lymph Node Metastases Reflected in IHC-Assessed Expression of Routine and Nonstandard Biomarkers. Front Oncol. 2021;11:660318.","journal-title":"Front Oncol"},{"issue":"6","key":"2331_CR78","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00432-024-05834-y","volume":"150","author":"M Ding","year":"2024","unstructured":"Ding M, Li M, Liu Q, Xu L. Biomarker conversion from primary breast cancer to synchronous axillary lymph node metastasis and neoadjuvant therapy response: a single-center analysis. J Cancer Res Clin Oncol. 2024;150(6):297.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2331_CR79","doi-asserted-by":"publisher","first-page":"103542","DOI":"10.1016\/j.ebiom.2021.103542","volume":"71","author":"B Chen","year":"2021","unstructured":"Chen B, Zhang G, Lai J, Xiao W, Li X, Li C, Mok H, Li K, Wang Y, Cao L, et al. Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours. EBioMedicine. 2021;71:103542.","journal-title":"EBioMedicine"},{"issue":"5","key":"2331_CR80","doi-asserted-by":"publisher","first-page":"595","DOI":"10.5858\/arpa.2013-0566-CP","volume":"138","author":"PL Fitzgibbons","year":"2014","unstructured":"Fitzgibbons PL, Dillon DA, Alsabeh R, Berman MA, Hayes DF, Hicks DG, Hughes KS, Nofech-Mozes S. Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast. Arch Pathol Lab Med. 2014;138(5):595\u2013601.","journal-title":"Arch Pathol Lab Med"},{"issue":"8 Suppl","key":"2331_CR81","first-page":"s4244","volume":"46","author":"KS McCarty Jr","year":"1986","unstructured":"McCarty KS Jr., Szabo E, Flowers JL, Cox EB, Leight GS, Miller L, Konrath J, Soper JT, Budwit DA, Creasman WT, et al. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res. 1986;46(8 Suppl):s4244\u20138.","journal-title":"Cancer Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02331-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02331-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02331-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T03:10:58Z","timestamp":1788145858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02331-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2331"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02331-7","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients whose samples were included in the tissue microarrays (TMAs) provided written informed consent for the use of their archival tissue for scientific research, in accordance with the Declaration of Helsinki. Construction of the TMAs was approved by the appropriate local Institutional Review Boards\/Ethics Committees. UIC IACUC ACC Number 19\u2013123 (mouse). For TMA, written consent was obtained from patients for the inclusion of their samples in this study and samples were collected in accordance with the Declaration of Helsinki, and approved by local ethics committees (Comite Etico de Investigaci\u00f3n Cl\u00ednica de Euskadi (CEIC-E)). From UIC OPRS, we received a Determination of No Human Subject research for the de-identified human samples in this study.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The study involved only de-identified data.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"151"}}